C, G., NE, S., T, W. F. L., GL, P., M, H., ED, G., . . . EL, H. (2021). NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector. PLoS pathogens, 17(6), e1009658. https://doi.org/10.1371/journal.ppat.1009658
Chicago Style (17th ed.) CitationC, Giogha, Scott NE, Wong Fok Lung T, Pollock GL, Harper M, Goddard-Borger ED, Pearson JS, and Hartland EL. "NleB2 from Enteropathogenic Escherichia Coli Is a Novel Arginine-glucose Transferase Effector." PLoS Pathogens 17, no. 6 (2021): e1009658. https://doi.org/10.1371/journal.ppat.1009658.
MLA (9th ed.) CitationC, Giogha, et al. "NleB2 from Enteropathogenic Escherichia Coli Is a Novel Arginine-glucose Transferase Effector." PLoS Pathogens, vol. 17, no. 6, 2021, p. e1009658, https://doi.org/10.1371/journal.ppat.1009658.